Richard Silver, M.D., discusses the success of Gleevac, the once-a-day pill that has turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. Read more
Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct an in-depth study of the molecular machinery driving the most aggressive form of prostate cancer. Most prostate cancers are a... Read more
David Rickman and Himisha Beltran will receive a grant from the Department of Defense to conduct an in-depth study of N-Myc and the molecular machinery driving neuroendocrine prostate cancer. Read more
NEW YORK (March 3, 2017) — Dr. Virginia Pascual, a renowned physician-scientist specializing in pediatric rheumatology, has been appointed the founding Gale and Ira Drukier Director of the Gale and Ira Drukier Institute for... Read more
A newly discovered type of genetic mutation that occurs frequently in cancer cells may provide clues about the disease’s origins and offer new therapeutic targets, according to new research from Weill Cornell Medicine and... Read more
Finola Hughes from TV's "General Hospital" and Ellen K. Ritchie, M.D. are teaming up to raise awareness for myeloproliferative disorder polycythemia vera. Read more
A study by Marcin Imielinski, M.D., Ph.D., illuminates a possible new type of driver of cancer: small (one-50 letter) insertions or deletions of DNA sequence, also called “indels,” in regions of the genome that do not code for proteins. Read more
A team of radiologists, oncologists, surgeons and other physicians are partnering with the International Cancer Expert Corps (ICEC) to create a Weill Cornell Medicine hub of global outreach for cancer care. Read more
The MORAL score for hepatocellular carcinoma is highly predictive of recurrence-free survival and can accurately identify patients who should not undergo liver transplant with a living donor, according to Karim J. Halazun, M.D. Read more
Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new study from UC San Francisco, Weill Cornell Medicine and three other medical centers. Read more
Video of If cancer didn’t metastasize, or spread, it would be easy to cure, says Dr. Lewis Cantley , the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. “We could merely cut it out, and... Read more